Skip to main content
. Author manuscript; available in PMC: 2012 Nov 1.
Published in final edited form as: Curr Pharm Biotechnol. 2012 May 1;13(6):819–826. doi: 10.2174/138920112800399284

Table 1. Blood COHb levels following interpertional administration of CORM-A1 in mice.

Blood COHb levels were measured by absorbance at 420 and 432nm. Percentage COHb was calculated from the A420/A432 ratio using previously published molar absorptivities of mouse hemoglobin, F1=1.301, F2=0.464, F3=2.053 [79]. CORM-A1 when administered at a concentration of 7.5 mg/kg resulted in a significant increase in blood COHb levels for up to 45 min post administration, n=6/group. * = P <0.05 as compared to baseline, iCORM-A1=inactive CORM-A1.

CORM-A1
Concentration
Blood COHb (Percentage of baseline)
Time Post Administration (min)
15 30 45 60 120
7.5mg/kg 147±10* 134±1* 118±1* 108±2 105±8
5mg/kg 105±11 112±8 94±5 90±4 94±5
3mg/kg 107±3 105±8 88±6 93±15 89±4
1.5mg/kg 105±12 102±7 100±10 100±3 100±2
iCORM-A1 (7.5 mg/kg) 101±10 93±7 93±9 90±2 100±8